Bmi1 Controls Tumor Development in an Ink4a/Arf-Independent Manner in a Mouse Model for Glioma

Sophia W.M. Bruggeman(University of Groningen), Maarten van Lohuizen(Oncode Institute), Olaf van Tellingen(Dutch Cancer Society), Ellen Tanger(The Netherlands Cancer Institute), Danielle Hulsman(The Netherlands Cancer Institute), Marleen Blom(The Netherlands Cancer Institute), Tessa Buckle(Leiden University Medical Center), John Zevenhoven(The Netherlands Cancer Institute)
Cancer Cell
October 1, 2007
10.1016/j.ccr.2007.08.032
Cited by 291

Related Papers

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
|Cell|1994|2.3k
Molecular Maps of the Reorganization of Genome-Nuclear Lamina Interactions during Differentiation
|Molecular Cell|2010|1.1k
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884